Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 13,275 | 79.0 | 19.91 | 0.85 | 4,935.00 |
| Sep 2026 | 13,201 | 79.1 | 20.00 | 0.85 | 4,957.00 |
| Sep 2026 | 12,280 | 78.1 | 22.08 | 0.85 | 4,869.00 |
| Sep 2026 | 12,280 | 78.1 | 22.08 | 0.85 | 4,869.00 |
| Sep 2026 | 12,280 | 78.1 | 22.08 | 0.85 | 4,869.00 |
| Sep 2026 | 12,280 | 78.1 | 22.08 | 0.85 | 4,869.00 |
| Oct 2026 | 12,424 | 76.3 | 21.62 | 0.85 | 4,767.30 |
| Oct 2026 | 12,082 | 74.4 | 21.12 | 0.85 | 4,656.90 |
Torrent Pharmaceuticals Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 48,350,000,000.0 | 41,280,000,000.0 | 32,510,000,000.0 | 32,460,000,000.0 |
| Net Profit | 5,660,000,000.0 | 3,890,000,000.0 | 6,350,000,000.0 | 5,910,000,000.0 |
| EPS | 14.9 | 11.5 | 18.8 | 17.4 |
Torrent Pharmaceuticals Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 137,529,900,000.0 | 113,172,500,000.0 | 105,623,100,000.0 | 94,636,900,000.0 |
| Net Profit | 21,633,700,000.0 | 19,112,500,000.0 | 16,563,800,000.0 | 12,452,300,000.0 |
| EPS | 63.9 | 56.5 | 48.9 | 36.8 |
Torrent Pharmaceuticals Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 443,119,600,000.0 | 149,897,400,000.0 | 150,605,800,000.0 | 150,118,500,000.0 | — |
| Total Liabilities | 267,271,300,000.0 | 73,990,500,000.0 | 82,044,300,000.0 | 88,137,800,000.0 | — |
| Total Equity | 83,884,300,000.0 | 75,906,900,000.0 | 68,561,500,000.0 | 61,980,700,000.0 | — |
Owes vs Owns
Torrent Pharmaceuticals Limited owed ₹0.60 for every ₹1 it owned in Mar 2026, up from ₹0.59 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.60× | 0.49× | 0.54× | 0.59× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Torrent Pharmaceuticals Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
How it's funded — Mar 2026
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,355.2 | 688.0 | 1,004.0 | 722.8 |
| Receivables | 3,030.9 | 1,866.5 | 1,844.3 | 1,943.8 |
| Inventory | 3,138.2 | 2,541.2 | 2,279.1 | 2,229.6 |
| Fixed assets (tangible) | 5,394.1 | 3,864.7 | 3,593.2 | 3,482.3 |
| Intangible assets | 28,453.2 | 4,602.1 | 4,920.9 | 5,427.0 |
| Long-term investments | 99.4 | 44.6 | 33.3 | 71.1 |
| Other assets | 1,841.0 | 1,382.6 | 1,385.9 | 1,135.2 |
| Liabilities & equity | ||||
| Short-term debt | 3,147.1 | 1,834.3 | 2,333.6 | 2,801.1 |
| Long-term debt | 11,651.2 | 1,191.8 | 1,603.8 | 2,496.2 |
| Payables | 2,357.6 | 1,820.0 | 2,089.3 | 1,678.8 |
| Other liabilities | 9,571.3 | 2,552.9 | 2,177.7 | 1,837.7 |
| Shareholders' equity | 17,584.8 | 7,590.7 | 6,856.1 | 6,198.1 |
| Net tangible assets | -20,064.8 | 2,988.6 | 1,935.3 | 771.1 |
Torrent Pharmaceuticals Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 30,227,100,000.0 | 25,851,100,000.0 | 32,660,800,000.0 | 23,681,300,000.0 | — |
| Investing Activities | -127,124,100,000.0 | -5,400,500,000.0 | -1,679,000,000.0 | -24,153,100,000.0 | — |
| Financing Activities | 101,506,000,000.0 | -22,979,900,000.0 | -27,796,400,000.0 | 773,600,000.0 | — |